{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T04:22:27Z","timestamp":1727497347639},"posted":{"date-parts":[[2024,6,25]]},"group-title":"In Review","reference-count":37,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,6,3]]},"abstract":"<title>Abstract<\/title>\n        <p>High ferritin is an important and sensitive biomarker for hemophagocytic lymphohistiocytosis (HLH), a diverse and deadly group of cytokine storm syndromes. Early action to prevent immunopathology in HLH often includes empiric immunomodulation, which can complicate etiologic work-up and prevent collection of early\/pre-treatment research samples. To address this, we instituted an alert system where serum ferritin\u2009&gt;\u20091000ng\/mL triggered real-time chart review, assessment of whether the value reflected \u201cinflammatory hyperferritnemia (IHF)\u201d, and biobanking of remnant samples from consenting IHF patients. We extracted relevant clinical data; periodically measured serum total IL-18, IL-18 binding protein (IL-18BP), and CXCL9; retrospectively classified patients by etiology into infectious, rheumatic, or immune dysregulation; and subjected a subgroup of samples to a 96-analyte biomarker screen. 180 patients were identified, 30.5% of which had IHF. Maximum ferritin levels were significantly higher in patients with IHF than with either hemoglobinopathy or transplant, and highly elevated total IL-18 levels were distinctive to patients with Stills Disease and\/or Macrophage Activation Syndrome (MAS). Multi-analyte analysis showed elevation in proteins associated with cytotoxic lymphocytes in all IHF samples when compared to healthy controls and depression of proteins such as ANGPT1 and VEGFR2 in samples from hyperferritinemic sepsis patients relative to non-sepsis controls. This single-center, real-time IFH screen proved feasible and efficient, validated prior observations about the specificity of IL-18, enabled early sample collection from a complex population, suggested a unique vascular biomarker signature in hyperferritinemic sepsis, and expanded our understanding of IHF heterogeneity.<\/p>","DOI":"10.21203\/rs.3.rs-4523502\/v1","type":"posted-content","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T20:24:34Z","timestamp":1719347074000},"source":"Crossref","is-referenced-by-count":0,"title":["Hyperferritinemia screening to aid identification and differentiation of patients with hyperinflammatory disorders"],"prefix":"10.21203","author":[{"given":"Hallie A.","family":"Carol","sequence":"first","affiliation":[{"name":"Division of Pediatric Rheumatology, The Children's Hospital of Philadelphia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam S.","family":"Mayer","sequence":"additional","affiliation":[{"name":"Division of Pediatric Rheumatology, The Children's Hospital of Philadelphia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.","family":"Zhang","sequence":"additional","affiliation":[{"name":"Division of Pediatric Allergy\/Immunology, University of Pittsburgh School of Medicine, UPMC Children\u2019s Hospital of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinh","family":"Dang","sequence":"additional","affiliation":[{"name":"Division of Pediatric Rheumatology, The Children's Hospital of Philadelphia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jemy","family":"Varghese","sequence":"additional","affiliation":[{"name":"Division of Pediatric Rheumatology, The Children's Hospital of Philadelphia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary","family":"Martinez","sequence":"additional","affiliation":[{"name":"Division of Pediatric Oncology, The Children\u2019s Hospital of Philadelphia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinne","family":"Schneider","sequence":"additional","affiliation":[{"name":"RK Mellon Institute for Pediatric Research & Pediatric Rheumatology, University of Pittsburgh School of Medicine, UPMC Children\u2019s Hospital of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joy (Elizabeth)","family":"Baker","sequence":"additional","affiliation":[{"name":"Division of Pediatric Rheumatology, Cincinnati Children\u2019s Hospital Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Tsoukas","sequence":"additional","affiliation":[{"name":"Division of Pediatric Rheumatology, Hospital for Sick Children,Toronto, ON"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward M.","family":"Behrens","sequence":"additional","affiliation":[{"name":"Division of Pediatric Rheumatology, The Children's Hospital of Philadelphia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randy Q.","family":"Cron","sequence":"additional","affiliation":[{"name":"Division of Pediatric Rheumatology, The University of Alabama at Birmingham"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Diorio","sequence":"additional","affiliation":[{"name":"Division of Pediatric Oncology, The Children\u2019s Hospital of Philadelphia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren A.","family":"Henderson","sequence":"additional","affiliation":[{"name":"Division of Immunology, Boston Children\u2019s Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grant","family":"Schulert","sequence":"additional","affiliation":[{"name":"Division of Pediatric Rheumatology, Cincinnati Children\u2019s Hospital Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pui","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Immunology, Boston Children\u2019s Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate F.","family":"Kernan","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, University of Pittsburgh School of Medicine, UPMC Children\u2019s Hospital of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott W.","family":"Canna","sequence":"additional","affiliation":[{"name":"Division of Pediatric Rheumatology, The Children's Hospital of Philadelphia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"8","key":"ref1","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s10067-012-1998-0","article-title":"Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases","volume":"31","author":"Lin CI","year":"2012","unstructured":"Lin CI, Yu HH, Lee JH, Wang LC, Lin YT, Yang YH, et al. Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases. Clin Rheumatol. 2012;31(8):1223\u201330.","journal-title":"Clin Rheumatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-med-061813-012806","article-title":"Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies","volume":"66","author":"Schulert GS","year":"2015","unstructured":"Schulert GS, Grom AA. Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies. Annu Rev Med. 2015;66:145\u201359.","journal-title":"Annu Rev Med"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/adc.85.5.421","article-title":"Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders","volume":"85","author":"Sawhney S","year":"2001","unstructured":"Sawhney S, Woo P, Murray KJ. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child. 2001;85(5):421\u20136.","journal-title":"Arch Dis Child"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jaci.2020.09.016","article-title":"Highways to hell: Mechanism-based management of cytokine storm syndromes","volume":"146","author":"Canna SW","year":"2020","unstructured":"Canna SW, Cron RQ. Highways to hell: Mechanism-based management of cytokine storm syndromes. J Allergy Clin Immunol. 2020;146(5):949\u201359.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter JI","year":"2007","unstructured":"Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124\u201331.","journal-title":"Pediatr Blood Cancer"},{"year":"2016","author":"Ravelli A","key":"ref6","unstructured":"Ravelli A, Minoia F, Davi S, Horne A, Bovis F, Pistorio A, et al. Arthritis Rheumatol. 2016;68(3):566\u201376. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis:A European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation Collaborative Initiative."},{"issue":"9","key":"ref7","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet L","year":"2014","unstructured":"Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan D, et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014;66(9):2613\u201320.","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"ref8","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1002\/art.42636","article-title":"The 2022 EULAR\/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis\/Macrophage Activation Syndrome (HLH\/MAS)","volume":"75","author":"Shakoory B","year":"2023","unstructured":"Shakoory B, Geerlinks A, Wilejto M, Kernan K, Hines M, Romano M, et al. The 2022 EULAR\/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis\/Macrophage Activation Syndrome (HLH\/MAS). Arthritis Rheumatol. 2023;75(10):1714\u201332.","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"ref9","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/intimm\/dxx031","article-title":"Hyperferritinemia and inflammation","volume":"29","author":"Kernan KF","year":"2017","unstructured":"Kernan KF, Carcillo JA. Hyperferritinemia and inflammation. Int Immunol. 2017;29(9):401\u20139.","journal-title":"Int Immunol"},{"issue":"7","key":"ref10","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1177\/0009922819837352","article-title":"C-Reactive Protein and Ferritin Are Associated With Organ Dysfunction and Mortality in Hospitalized Children","volume":"58","author":"Horvat CM","year":"2019","unstructured":"Horvat CM, Bell J, Kantawala S, Au AK, Clark RSB, Carcillo JA. C-Reactive Protein and Ferritin Are Associated With Organ Dysfunction and Mortality in Hospitalized Children. Clin Pediatr (Phila). 2019;58(7):752\u201360.","journal-title":"Clin Pediatr (Phila)"},{"issue":"13","key":"ref11","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1182\/blood-2017-12-820852","article-title":"Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome","volume":"131","author":"Weiss ES","year":"2018","unstructured":"Weiss ES, Girard-Guyonvarc'h C, Holzinger D, de Jesus AA, Tariq Z, Picarsic J, et al. Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome. Blood. 2018;131(13):1442\u201355.","journal-title":"Blood"},{"issue":"19","key":"ref12","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMoa1911326","article-title":"Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis","volume":"382","author":"Locatelli F","year":"2020","unstructured":"Locatelli F, Jordan MB, Allen C, Cesaro S, Rizzari C, Rao A, et al. Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis. N Engl J Med. 2020;382(19):1811\u201322.","journal-title":"N Engl J Med"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/annrheumdis-2015-209020","article-title":"Elevated circulating levels of interferon-gamma and interferon-gamma-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"76","author":"Bracaglia C","year":"2017","unstructured":"Bracaglia C, de Graaf K, Pires Marafon D, Guilhot F, Ferlin W, Prencipe G, et al. Elevated circulating levels of interferon-gamma and interferon-gamma-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Ann Rheum Dis. 2017;76(1):166\u201372.","journal-title":"Ann Rheum Dis"},{"key":"ref14","article-title":"Systemic and Nodular Hyperinflammation in a Patient with Refractory Familial Hemophagocytic Lymphohistiocytosis 2","author":"Segal JE","year":"2021","unstructured":"Segal JE, Daley JD, Barnum JL, Salgado CM, Reyes-Mugica M, Schneider C et al. Systemic and Nodular Hyperinflammation in a Patient with Refractory Familial Hemophagocytic Lymphohistiocytosis 2. J Clin Immunol. 2021.","journal-title":"J Clin Immunol"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"e000161","DOI":"10.1136\/rmdopen-2015-000161","article-title":"Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"2","author":"Ravelli A","year":"2016","unstructured":"Ravelli A, Minoia F, Davi S, Horne A, Bovis F, Pistorio A, et al. Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. RMD Open. 2016;2(1):e000161.","journal-title":"RMD Open"},{"issue":"7","key":"ref16","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.42099","article-title":"Identification of Distinct Inflammatory Programs and Biomarkers in Systemic Juvenile Idiopathic Arthritis and Related Lung Disease by Serum Proteome Analysis","volume":"74","author":"Chen G","year":"2022","unstructured":"Chen G, Deutsch GH, Schulert GS, Zheng H, Jang S, Trapnell B, et al. Identification of Distinct Inflammatory Programs and Biomarkers in Systemic Juvenile Idiopathic Arthritis and Related Lung Disease by Serum Proteome Analysis. Arthritis Rheumatol. 2022;74(7):1271\u201383.","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/acr2.11048","article-title":"Ferritin to Erythrocyte Sedimentation Rate Ratio: Simple Measure to Identify Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis","volume":"1","author":"Eloseily EMA","year":"2019","unstructured":"Eloseily EMA, Minoia F, Crayne CB, Beukelman T, Ravelli A, Cron RQ. Ferritin to Erythrocyte Sedimentation Rate Ratio: Simple Measure to Identify Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis. ACR Open Rheumatol. 2019;1(6):345\u20139.","journal-title":"ACR Open Rheumatol"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/CCM.0000000000004131","article-title":"Hyperferritinemia in Critically Ill Patients","volume":"48","author":"Lachmann G","year":"2020","unstructured":"Lachmann G, Knaak C, Vorderwulbecke G, La Rosee P, Balzer F, Schenk T, et al. Hyperferritinemia in Critically Ill Patients. Crit Care Med. 2020;48(4):459\u201365.","journal-title":"Crit Care Med"},{"issue":"10","key":"ref19","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s00277-017-3072-0","article-title":"Elevated serum ferritin is not specific for hemophagocytic lymphohistiocytosis","volume":"96","author":"Otrock ZK","year":"2017","unstructured":"Otrock ZK, Hock KG, Riley SB, de Witte T, Eby CS, Scott MG. Elevated serum ferritin is not specific for hemophagocytic lymphohistiocytosis. Ann Hematol. 2017;96(10):1667\u201372.","journal-title":"Ann Hematol"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s12185-015-1813-1","article-title":"Evaluating the optimal serum ferritin level to identify hemophagocytic lymphohistiocytosis in the critical care setting","volume":"102","author":"Saeed H","year":"2015","unstructured":"Saeed H, Woods RR, Lester J, Herzig R, Gul Z, Monohan G. Evaluating the optimal serum ferritin level to identify hemophagocytic lymphohistiocytosis in the critical care setting. Int J Hematol. 2015;102(2):195\u20139.","journal-title":"Int J Hematol"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/PCC.0b013e3181a1ae08","article-title":"Secondary hemophagocytic lymphohistiocytosis and severe sepsis\/ systemic inflammatory response syndrome\/multiorgan dysfunction syndrome\/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation","volume":"10","author":"Castillo L","year":"2009","unstructured":"Castillo L, Carcillo J. Secondary hemophagocytic lymphohistiocytosis and severe sepsis\/ systemic inflammatory response syndrome\/multiorgan dysfunction syndrome\/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation. Pediatr Crit Care Med. 2009;10(3):387\u201392.","journal-title":"Pediatr Crit Care Med"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/pbc.21423","article-title":"Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis","volume":"50","author":"Allen CE","year":"2008","unstructured":"Allen CE, Yu X, Kozinetz CA, McClain KL. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2008;50(6):1227\u201335.","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"ref23","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/RHU.0b013e31829ce01f","article-title":"Causes and significance of markedly elevated serum ferritin levels in an academic medical center","volume":"19","author":"Moore C","year":"2013","unstructured":"Moore C Jr., Ormseth M, Fuchs H. Causes and significance of markedly elevated serum ferritin levels in an academic medical center. J Clin Rheumatol. 2013;19(6):324\u20138.","journal-title":"J Clin Rheumatol"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/cei.13543","article-title":"The role of interleukin-18 in the diagnosis and monitoring of hemophagocytic lymphohistiocytosis\/macrophage activation syndrome - a systematic review","volume":"203","author":"Krei JM","year":"2021","unstructured":"Krei JM, Moller HJ, Larsen JB. The role of interleukin-18 in the diagnosis and monitoring of hemophagocytic lymphohistiocytosis\/macrophage activation syndrome - a systematic review. Clin Exp Immunol. 2021;203(2):174\u201382.","journal-title":"Clin Exp Immunol"},{"key":"ref25","article-title":"A dysregulated interleukin-18\/interferon-gamma\/CXCL9 axis impacts treatment response to canakinumab in systemic juvenile idiopathic arthritis","author":"Hinze T","year":"2021","unstructured":"Hinze T, Kessel C, Hinze CH, Seibert J, Gram H, Foell D. A dysregulated interleukin-18\/interferon-gamma\/CXCL9 axis impacts treatment response to canakinumab in systemic juvenile idiopathic arthritis. Rheumatology (Oxford). 2021.","journal-title":"Rheumatology (Oxford)"},{"issue":"17","key":"ref26","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1182\/bloodadvances.2021004287","article-title":"IFN-gamma signature in the plasma proteome distinguishes pediatric hemophagocytic lymphohistiocytosis from sepsis and SIRS","volume":"5","author":"Lin H","year":"2021","unstructured":"Lin H, Scull BP, Goldberg BR, Abhyankar HA, Eckstein OE, Zinn DJ, et al. IFN-gamma signature in the plasma proteome distinguishes pediatric hemophagocytic lymphohistiocytosis from sepsis and SIRS. Blood Adv. 2021;5(17):3457\u201367.","journal-title":"Blood Adv"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","article-title":"Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial","volume":"44","author":"Shakoory B","year":"2016","unstructured":"Shakoory B, Carcillo JA, Chatham WW, Amdur RL, Zhao H, Dinarello CA, et al. Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial. Crit Care Med. 2016;44(2):275\u201381.","journal-title":"Crit Care Med"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12916-017-0930-5","article-title":"Macrophage activation-like syndrome: an immunological entity associated with rapid progression to death in sepsis","volume":"15","author":"Kyriazopoulou E","year":"2017","unstructured":"Kyriazopoulou E, Leventogiannis K, Norrby-Teglund A, Dimopoulos G, Pantazi A, Orfanos SE, et al. Macrophage activation-like syndrome: an immunological entity associated with rapid progression to death in sepsis. BMC Med. 2017;15(1):172.","journal-title":"BMC Med"},{"key":"ref29","first-page":"10","article-title":"An open label trial of anakinra to prevent respiratory failure in COVID-19","author":"Kyriazopoulou E","year":"2021","unstructured":"Kyriazopoulou E, Panagopoulos P, Metallidis S, Dalekos GN, Poulakou G, Gatselis N et al. An open label trial of anakinra to prevent respiratory failure in COVID-19. Elife. 2021;10.","journal-title":"Elife"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40635-022-00433-y","article-title":"Sepsis with liver dysfunction and coagulopathy predicts an inflammatory pattern of macrophage activation","volume":"10","author":"Anderko RR","year":"2022","unstructured":"Anderko RR, Gomez H, Canna SW, Shakoory B, Angus DC, Yealy DM, et al. Sepsis with liver dysfunction and coagulopathy predicts an inflammatory pattern of macrophage activation. Intensive Care Med Exp. 2022;10(1):6.","journal-title":"Intensive Care Med Exp"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12014-022-09389-3","article-title":"Novel plasma protein biomarkers from critically ill sepsis patients","volume":"19","author":"Nynatten LR","year":"2022","unstructured":"Van Nynatten LR, Slessarev M, Martin CM, Leligdowicz A, Miller MR, Patel MA, et al. Novel plasma protein biomarkers from critically ill sepsis patients. Clin Proteom. 2022;19(1):50.","journal-title":"Clin Proteom"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/SHK.0000000000000903","article-title":"Low Serum Angiopoietin-1, High Serum Angiopoietin-2, and High Ang-2\/Ang-1 Protein Ratio are Associated with Early Onset Sepsis in Surinamese Newborns","volume":"48","author":"Zonneveld R","year":"2017","unstructured":"Zonneveld R, Jongman R, Juliana A, Zijlmans W, Plotz F, Molema G, et al. Low Serum Angiopoietin-1, High Serum Angiopoietin-2, and High Ang-2\/Ang-1 Protein Ratio are Associated with Early Onset Sepsis in Surinamese Newborns. Shock. 2017;48(6):638\u201343.","journal-title":"Shock"},{"issue":"12","key":"ref33","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.it.2006.10.004","article-title":"Angiopoietins: a link between angiogenesis and inflammation","volume":"27","author":"Fiedler U","year":"2006","unstructured":"Fiedler U, Augustin HG. Angiopoietins: a link between angiogenesis and inflammation. Trends Immunol. 2006;27(12):552\u20138.","journal-title":"Trends Immunol"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4161\/viru.24906","article-title":"Dysregulation of the angiopoietin-Tie-2 axis in sepsis and ARDS","volume":"4","author":"Parikh SM","year":"2013","unstructured":"Parikh SM. Dysregulation of the angiopoietin-Tie-2 axis in sepsis and ARDS. Virulence. 2013;4(6):517\u201324.","journal-title":"Virulence"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"155029","DOI":"10.1016\/j.cyto.2020.155029","article-title":"The ratio of plasma angiopoietin-2 to angiopoietin-1 as a prognostic biomarker in patients with sepsis","volume":"129","author":"Seol CH","year":"2020","unstructured":"Seol CH, Yong SH, Shin JH, Lee SH, Leem AY, Park MS, et al. The ratio of plasma angiopoietin-2 to angiopoietin-1 as a prognostic biomarker in patients with sepsis. Cytokine. 2020;129:155029.","journal-title":"Cytokine"},{"issue":"5","key":"ref36","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/(SICI)1096-911X(199705)28:5<342::AID-MPO3>3.0.CO;2-H","article-title":"HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society","volume":"28","author":"Henter JI","year":"1997","unstructured":"Henter JI, Aric\u00f2 M, Egeler RM, Elinder G, Favara BE, Filipovich AH. HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. Med Pediatr Oncol. 1997;28(5):342\u20137.","journal-title":"Med Pediatr Oncol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1182\/blood-2004-12-4935","article-title":"A functional analysis of the putative polymorphisms A91V and N252S and 22 missense perforin mutations associated with familial hemophagocytic lymphohistiocytosis","volume":"105","author":"Voskoboinik I","year":"2005","unstructured":"Voskoboinik I, Thia M-C, Trapani JA. A functional analysis of the putative polymorphisms A91V and N252S and 22 missense perforin mutations associated with familial hemophagocytic lymphohistiocytosis. Blood J. 2005;105:4700\u20136.","journal-title":"Blood J"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4523502\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4523502\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T11:55:35Z","timestamp":1727438135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4523502\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,25]]},"references-count":37,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-4523502\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1007\/s10875-024-01797-4","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,6,25]]},"subtype":"preprint"}}